BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2277375)

  • 1. Role of new cephamycins in the management of obstetric and gynecologic infections.
    Jones RN
    J Reprod Med; 1990 Nov; 35(11 Suppl):1070-7. PubMed ID: 2277375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cephamycins in obstetrics and gynecology.
    Sweet RL
    J Reprod Med; 1990 Nov; 35(11 Suppl):1064-9. PubMed ID: 2277374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotetan: comparative and noncomparative studies in obstetric and gynecologic infections.
    Knuppel RA; O'Bryan D; Lake M
    South Med J; 1988 Feb; 81(2):185-8. PubMed ID: 3422519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefmetazole (CS-1170), a "new" cephamycin with a decade of clinical experience.
    Jones RN
    Diagn Microbiol Infect Dis; 1989; 12(5):367-79. PubMed ID: 2692950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefmetazole sodium: pharmacology, pharmacokinetics, and clinical trials.
    Schentag JJ
    Pharmacotherapy; 1991; 11(1):2-19. PubMed ID: 2020609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulary evaluation of second-generation cephamycin derivatives using decision analysis.
    Barriere SL
    Am J Hosp Pharm; 1991 Oct; 48(10):2146-50. PubMed ID: 1781469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cephalosporins.
    Martens MG
    Obstet Gynecol Clin North Am; 1989 Jun; 16(2):291-304. PubMed ID: 2674797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotetan in the treatment of obstetric and gynecologic infections.
    Poindexter AN; Sweet R; Ritter M
    Am J Obstet Gynecol; 1986 Apr; 154(4):946-50. PubMed ID: 3515949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of ceftriaxone: a review.
    Cleeland R; Squires E
    Am J Med; 1984 Oct; 77(4C):3-11. PubMed ID: 6093515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods.
    Jones RN; Barry AL; Fuchs PC; Thornsberry C
    J Clin Microbiol; 1986 Dec; 24(6):1055-9. PubMed ID: 3097064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
    Esposito S; Galante D; Barba D
    Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of moxalactam.
    Reed MD; Bertino JS; Aronoff SC; Speck WT; Blumer JL
    Clin Pharm; 1982; 1(2):124-34. PubMed ID: 6224626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenems and penems.
    Faro S
    Obstet Gynecol Clin North Am; 1989 Jun; 16(2):271-7. PubMed ID: 2674795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefoxitin and cephamycins: microbiological studies.
    Stapley EO; Birnbaum J; Miller AK; Wallick H; Hendlin D; Woodruff HB
    Rev Infect Dis; 1979; 1(1):73-89. PubMed ID: 400941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefmenoxime therapy for gynecologic and obstetric infections.
    Rao B; Savage EW; Chuah SK; Bansal MB; Dhawan VK; Thadepalli H
    Obstet Gynecol; 1985 Sep; 66(3):377-83. PubMed ID: 3860790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Richards DM
    Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The penicillins.
    Campbell BA; Cox SM
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):435-47. PubMed ID: 1436922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cephalosporins: rationale for clinical use.
    Molavi A
    Am Fam Physician; 1991 Mar; 43(3):937-48. PubMed ID: 2000736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro action of moxalactam on hospital bacteria. Results of a multicenter survey].
    Duval J; Deforges L; Bergogne-Berezin E; Chabbert YA; Courtieu AL; Cluzel R; Dabernat H; Witchitz JL
    Sem Hop; 1983 Jun; 59(26):1949-52. PubMed ID: 6310784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.